Procedures for the clinical investigation of a topical corticosteroid.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004485:Eczema / Q000188:drug therapy; D005446:Fluocinolone Acetonide / Q000627:therapeutic use; D005938:Glucocorticoids; D006801:Humans; D007664:Ketosteroids / Q000627:therapeutic use; D008722:Methods; D008954:Models, Biological; D014677:Pharmaceutical Vehicles; D010919:Placebos; D011244:Pregnadienediols / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy; D013223:Statistics as Topic; D013258:Steroids, Chlorinated / Q000627:therapeutic use; D013259:Steroids, Fluorinated / Q000627:therapeutic use; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D007664:Ketosteroids; D014677:Pharmaceutical Vehicles; D010919:Placebos; D011244:Pregnadienediols; D013258:Steroids, Chlorinated; D013259:Steroids, Fluorinated; D005446:Fluocinolone Acetonide